BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31656041)

  • 21. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems.
    Lau YY; Okochi H; Huang Y; Benet LZ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):762-71. PubMed ID: 16258024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin prevents development of kindling by modulating hippocampal levels of dopamine, glutamate, and GABA in mice.
    Sehar N; Agarwal NB; Vohora D; Raisuddin S
    Epilepsy Behav; 2015 Jan; 42():48-53. PubMed ID: 25499163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific Inhibition of the Distribution of Lobeglitazone to the Liver by Atorvastatin in Rats: Evidence for a Rat Organic Anion Transporting Polypeptide 1B2-Mediated Interaction in Hepatic Transport.
    Yim CS; Jeong YS; Lee SY; Pyeon W; Ryu HM; Lee JH; Lee KR; Maeng HJ; Chung SJ
    Drug Metab Dispos; 2017 Mar; 45(3):246-259. PubMed ID: 28069721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs.
    Podszun MC; Grebenstein N; Hofmann U; Frank J
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):452-8. PubMed ID: 23200775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
    Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose atorvastatin improves vascular endothelial function in patients with leukoaraiosis.
    Xue J; Wu Z; Gong S; Qin S; Gu A
    J Clin Lab Anal; 2020 Mar; 34(3):e23081. PubMed ID: 32154613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Rooibos (Aspalathus linearis) extract on atorvastatin-induced toxicity in C3A liver cells.
    Millar DA; Bowles S; Windvogel SL; Louw J; Muller CJF
    J Cell Physiol; 2020 Dec; 235(12):9487-9496. PubMed ID: 32458430
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Lei HP; Qin M; Cai LY; Wu H; Tang L; Liu JE; Deng CY; Liu YB; Zhu Q; Li HP; Hu W; Yang M; Zhu YZ; Zhong SL
    Front Pharmacol; 2021; 12():586973. PubMed ID: 33762934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of hepatic function, oxidant/antioxidant status, and histopathological changes in rats treated with atorvastatin: Effect of dose and acute intoxication with acetaminophen.
    Farag MM; Mohamed MB; Youssef EA
    Hum Exp Toxicol; 2015 Aug; 34(8):828-37. PubMed ID: 25425547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin Inhibited ROS Generation and Increased IL-1β And IL-6 Release by Mononuclear Cells from Diabetic Patients.
    Dos Anjos PMF; Volpe CMO; Miranda TC; Nogueira-Machado JA
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1207-1215. PubMed ID: 31416412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
    Wolffenbuttel BH; Franken AA; Vincent HH;
    J Intern Med; 2005 Jun; 257(6):531-9. PubMed ID: 15910557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Analysis of the Transporter-Mediated Drug-Drug Interaction Between Atorvastatin and Rifampicin Using a Stable Isotope-IV Method.
    Yamashita S; Hasegawa T; Tachihara M; Minami K; Higashino H; Togashi K; Mutaguchi K; Kataoka M
    J Pharm Sci; 2017 Sep; 106(9):2671-2677. PubMed ID: 28457720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
    Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of atorvastatin on sevoflurane postconditioning in in vivo rabbit hearts.
    Kagawa K; Imaizumi U; Fuchida S; Sanuki T
    J Oral Biosci; 2021 Sep; 63(3):253-258. PubMed ID: 34280533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
    Jacobsen W; Kuhn B; Soldner A; Kirchner G; Sewing KF; Kollman PA; Benet LZ; Christians U
    Drug Metab Dispos; 2000 Nov; 28(11):1369-78. PubMed ID: 11038166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients.
    Gervasoni C; Riva A; Rizzardini G; Clementi E; Galli M; Cattaneo D
    Antivir Ther; 2015; 20(4):449-51. PubMed ID: 25279606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
    Pérez de Isla L; Arroyo-Olivares R; Muñiz-Grijalvo O; Diaz-Díaz JL; Zambón D; Fuentes F; Sánchez Muñoz-Torrero JF; Mediavilla JD; González-Estrada A; Miramontes-González JP; de Andrés R; Mauri M; Mosquera D; Cepeda JM; Suárez L; Barba-Romero MÁ; Argüeso R; Álvarez-Baños P; Michán A; Romero-Jiménez MJ; García-Cruces J; Padró T; Alonso R; Mata P
    J Clin Lipidol; 2019; 13(6):989-996. PubMed ID: 31706904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia aggravates the burden of yellowstripe goby (Mugilogobius chulae) under atorvastatin exposure.
    Wang Y; Tang T; Ren J; Zhao Y; Hou Y; Nie X
    Aquat Toxicol; 2023 Feb; 255():106381. PubMed ID: 36587518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of genetic variants of selected cytochrome P450 isoenzymes on pharmacokinetics and pharmacodynamics of clopidogrel in patients co-treated with atorvastatin or rosuvastatin.
    Karaźniewicz-Łada M; Krzyżańska D; Danielak D; Rzeźniczak J; Główka F; Słomczyński M; Burchardt P
    Eur J Clin Pharmacol; 2020 Mar; 76(3):419-430. PubMed ID: 31897532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia.
    Ballantyne CM; Lipka LJ; Sager PT; Strony J; Alizadeh J; Suresh R; Veltri EP
    Int J Clin Pract; 2004 Jul; 58(7):653-8. PubMed ID: 15311720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.